Integra LifeSciences Holdings Corporation (IART)
USD 20.06
(-7.9%)
USD 20.06
(-7.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 836.39 Million USD | -2.33% |
| 2022 | 731.39 Million USD | -2.14% |
| 2021 | 747.41 Million USD | 6.82% |
| 2020 | 699.66 Million USD | -11.9% |
| 2019 | 794.2 Million USD | 0.54% |
| 2018 | 789.94 Million USD | 11.59% |
| 2017 | 707.92 Million USD | 34.17% |
| 2016 | 527.64 Million USD | 10.71% |
| 2015 | 476.6 Million USD | -6.54% |
| 2014 | 509.96 Million USD | 11.09% |
| 2013 | 459.03 Million USD | 3.7% |
| 2012 | 442.66 Million USD | 3.91% |
| 2011 | 426.01 Million USD | 16.66% |
| 2010 | 365.18 Million USD | 7.49% |
| 2009 | 339.74 Million USD | -4.13% |
| 2008 | 354.36 Million USD | 31.98% |
| 2007 | 268.49 Million USD | 39.67% |
| 2006 | 192.23 Million USD | 65.3% |
| 2005 | 116.29 Million USD | -1.23% |
| 2004 | 117.74 Million USD | 56.26% |
| 2003 | 75.35 Million USD | 66.21% |
| 2002 | 45.33 Million USD | 5.09% |
| 2001 | 43.14 Million USD | -23.72% |
| 2000 | 56.55 Million USD | 70.86% |
| 1999 | 33.1 Million USD | 29.8% |
| 1998 | 25.5 Million USD | -10.53% |
| 1997 | 28.5 Million USD | 59.22% |
| 1996 | 17.9 Million USD | 40.94% |
| 1995 | 12.7 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 204.62 Million USD | 5.66% |
| 2024 Q1 | 202.87 Million USD | 13.91% |
| 2024 Q2 | 197.21 Million USD | -2.79% |
| 2023 Q4 | 178.09 Million USD | -7.12% |
| 2023 Q1 | 196.48 Million USD | 7.82% |
| 2023 FY | 714.31 Million USD | -2.33% |
| 2023 Q3 | 191.75 Million USD | -1.42% |
| 2023 Q2 | 194.52 Million USD | -1.0% |
| 2022 FY | 731.39 Million USD | -2.14% |
| 2022 Q3 | 171.69 Million USD | -9.42% |
| 2022 Q4 | 182.24 Million USD | 6.14% |
| 2022 Q2 | 189.54 Million USD | 0.87% |
| 2022 Q1 | 187.9 Million USD | -1.65% |
| 2021 Q1 | 183.53 Million USD | -2.86% |
| 2021 Q3 | 185.95 Million USD | -0.49% |
| 2021 Q4 | 191.05 Million USD | 2.74% |
| 2021 FY | 747.41 Million USD | 6.82% |
| 2021 Q2 | 186.87 Million USD | 1.82% |
| 2020 Q1 | 193.74 Million USD | -5.3% |
| 2020 Q3 | 177.87 Million USD | 27.87% |
| 2020 Q4 | 188.93 Million USD | 6.21% |
| 2020 FY | 699.66 Million USD | -11.9% |
| 2020 Q2 | 139.1 Million USD | -28.2% |
| 2019 Q2 | 194.01 Million USD | -2.24% |
| 2019 Q3 | 197.15 Million USD | 1.62% |
| 2019 Q4 | 204.58 Million USD | 3.77% |
| 2019 FY | 794.2 Million USD | 0.54% |
| 2019 Q1 | 198.47 Million USD | -2.11% |
| 2018 Q4 | 202.74 Million USD | 1.92% |
| 2018 Q2 | 200.99 Million USD | 7.32% |
| 2018 Q1 | 187.28 Million USD | -12.16% |
| 2018 FY | 789.94 Million USD | 11.59% |
| 2018 Q3 | 198.93 Million USD | -1.02% |
| 2017 Q2 | 166.18 Million USD | 2.52% |
| 2017 Q3 | 166.43 Million USD | 0.15% |
| 2017 Q4 | 213.21 Million USD | 28.11% |
| 2017 FY | 707.92 Million USD | 34.17% |
| 2017 Q1 | 162.09 Million USD | 25.19% |
| 2016 Q3 | 130.9 Million USD | -4.7% |
| 2016 Q4 | 129.47 Million USD | -1.1% |
| 2016 FY | 527.64 Million USD | 10.71% |
| 2016 Q2 | 137.36 Million USD | 5.77% |
| 2016 Q1 | 129.87 Million USD | 2.14% |
| 2015 Q4 | 127.15 Million USD | -2.42% |
| 2015 Q1 | 130.15 Million USD | 1.66% |
| 2015 Q2 | 143.58 Million USD | 10.32% |
| 2015 Q3 | 130.3 Million USD | -9.25% |
| 2015 FY | 476.6 Million USD | -6.54% |
| 2014 Q4 | 128.02 Million USD | 1.59% |
| 2014 Q3 | 126.01 Million USD | -4.52% |
| 2014 FY | 509.96 Million USD | 11.09% |
| 2014 Q1 | 123.93 Million USD | 6.76% |
| 2014 Q2 | 131.98 Million USD | 6.49% |
| 2013 Q2 | 114.5 Million USD | -1.66% |
| 2013 Q4 | 116.08 Million USD | 3.63% |
| 2013 FY | 459.03 Million USD | 3.7% |
| 2013 Q1 | 116.42 Million USD | 2.18% |
| 2013 Q3 | 112.02 Million USD | -2.17% |
| 2012 Q2 | 113.87 Million USD | 9.45% |
| 2012 Q3 | 110.8 Million USD | -2.7% |
| 2012 Q4 | 113.94 Million USD | 2.84% |
| 2012 FY | 442.66 Million USD | 3.91% |
| 2012 Q1 | 104.04 Million USD | -7.95% |
| 2011 Q3 | 105.24 Million USD | -6.44% |
| 2011 Q1 | 95.24 Million USD | -3.46% |
| 2011 Q2 | 112.49 Million USD | 18.1% |
| 2011 Q4 | 113.03 Million USD | 7.4% |
| 2011 FY | 426.01 Million USD | 16.66% |
| 2010 Q3 | 90.13 Million USD | 0.65% |
| 2010 Q1 | 86.83 Million USD | -5.35% |
| 2010 FY | 365.18 Million USD | 7.49% |
| 2010 Q4 | 98.66 Million USD | 9.46% |
| 2010 Q2 | 89.55 Million USD | 3.13% |
| 2009 Q4 | 91.73 Million USD | 7.36% |
| 2009 Q1 | 80.55 Million USD | -0.88% |
| 2009 Q2 | 82.01 Million USD | 1.82% |
| 2009 FY | 339.74 Million USD | -4.13% |
| 2009 Q3 | 85.44 Million USD | 4.18% |
| 2008 Q4 | 81.26 Million USD | -35.3% |
| 2008 FY | 354.36 Million USD | 31.98% |
| 2008 Q3 | 125.6 Million USD | 69.18% |
| 2008 Q2 | 74.24 Million USD | 1.34% |
| 2008 Q1 | 73.26 Million USD | -8.04% |
| 2007 FY | 268.49 Million USD | 39.67% |
| 2007 Q4 | 79.66 Million USD | 21.04% |
| 2007 Q3 | 65.81 Million USD | 1.16% |
| 2007 Q1 | 57.95 Million USD | 7.72% |
| 2007 Q2 | 65.06 Million USD | 12.27% |
| 2006 Q2 | 45.59 Million USD | 28.16% |
| 2006 Q3 | 57.27 Million USD | 25.63% |
| 2006 Q4 | 53.8 Million USD | -6.06% |
| 2006 FY | 192.23 Million USD | 65.3% |
| 2006 Q1 | 35.57 Million USD | 19.3% |
| 2005 FY | 116.29 Million USD | -1.23% |
| 2005 Q4 | 29.81 Million USD | 9.51% |
| 2005 Q1 | 28.75 Million USD | 15.19% |
| 2005 Q2 | 30.49 Million USD | 6.07% |
| 2005 Q3 | 27.22 Million USD | -10.71% |
| 2004 Q1 | 20.71 Million USD | -17.46% |
| 2004 Q4 | 24.95 Million USD | -48.96% |
| 2004 Q3 | 48.89 Million USD | 110.99% |
| 2004 Q2 | 23.17 Million USD | 11.89% |
| 2004 FY | 117.74 Million USD | 56.26% |
| 2003 Q1 | 15.63 Million USD | 71.65% |
| 2003 FY | 75.35 Million USD | 66.21% |
| 2003 Q4 | 25.09 Million USD | 45.34% |
| 2003 Q3 | 17.26 Million USD | -0.52% |
| 2003 Q2 | 17.35 Million USD | 11.0% |
| 2002 Q4 | 9.11 Million USD | -33.4% |
| 2002 FY | 45.33 Million USD | 5.09% |
| 2002 Q1 | 11.06 Million USD | -25.17% |
| 2002 Q2 | 11.48 Million USD | 3.82% |
| 2002 Q3 | 13.67 Million USD | 19.09% |
| 2001 FY | 43.14 Million USD | -23.72% |
| 2001 Q2 | 9.61 Million USD | -10.17% |
| 2001 Q3 | 9.43 Million USD | -1.96% |
| 2001 Q4 | 14.78 Million USD | 56.79% |
| 2001 Q1 | 10.7 Million USD | -58.17% |
| 2000 Q1 | 9.45 Million USD | 47.8% |
| 2000 Q3 | 10.62 Million USD | -2.32% |
| 2000 Q4 | 25.6 Million USD | 141.04% |
| 2000 FY | 56.55 Million USD | 70.86% |
| 2000 Q2 | 10.87 Million USD | 14.95% |
| 1999 Q1 | 6.1 Million USD | 1.67% |
| 1999 Q3 | 8.7 Million USD | -7.45% |
| 1999 Q4 | 6.4 Million USD | -26.44% |
| 1999 FY | 33.1 Million USD | 29.8% |
| 1999 Q2 | 9.4 Million USD | 54.1% |
| 1998 FY | 25.5 Million USD | -10.53% |
| 1998 Q3 | 5.9 Million USD | -10.61% |
| 1998 Q4 | 6 Million USD | 1.69% |
| 1998 Q1 | 7.1 Million USD | -46.62% |
| 1998 Q2 | 6.6 Million USD | -7.04% |
| 1997 Q2 | 5.1 Million USD | 15.91% |
| 1997 FY | 28.5 Million USD | 59.22% |
| 1997 Q4 | 13.3 Million USD | 137.5% |
| 1997 Q3 | 5.6 Million USD | 9.8% |
| 1997 Q1 | 4.4 Million USD | -4.35% |
| 1996 FY | 17.9 Million USD | 40.94% |
| 1996 Q1 | 3.9 Million USD | 0.0% |
| 1996 Q2 | 4.8 Million USD | 23.08% |
| 1996 Q3 | 4.5 Million USD | -6.25% |
| 1996 Q4 | 4.6 Million USD | 2.22% |
| 1995 Q4 | 3.9 Million USD | 11.43% |
| 1995 FY | 12.7 Million USD | 0.0% |
| 1995 Q3 | 3.5 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -7351.809% |
| Cerus Corporation | 143.15 Million USD | -484.256% |
| OrthoPediatrics Corp. | 137.01 Million USD | -510.42% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -7262.036% |
| Talis Biomedical Corporation | 67.18 Million USD | -1144.889% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -3252.806% |
| Inogen, Inc. | 236.08 Million USD | -254.275% |
| Spectral AI, Inc. | 20.86 Million USD | -3908.776% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -1393.635% |
| CVRx, Inc. | 76.14 Million USD | -998.462% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -23607.255% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -6597.021% |
| Orthofix Medical Inc. | 667.42 Million USD | -25.316% |
| Venus Concept Inc. | 80.47 Million USD | -939.305% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -1378.297% |
| Bioventus Inc. | 409.91 Million USD | -104.039% |
| BrainsWay Ltd. | 28.01 Million USD | -2885.192% |
| Envoy Medical, Inc. | 17.89 Million USD | -4573.098% |
| electroCore, Inc. | 32.03 Million USD | -2511.192% |
| IceCure Medical Ltd | 16.87 Million USD | -4856.097% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -1871.133% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -4643.32% |
| MaxCyte, Inc. | 84.84 Million USD | -885.787% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -6638.694% |
| Nexalin Technology, Inc. | 5.78 Million USD | -14367.039% |
| PAVmed Inc | 64.82 Million USD | -1190.189% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -1537.478% |
| RxSight, Inc. | 103.85 Million USD | -705.384% |
| Sight Sciences, Inc. | 126.44 Million USD | -561.445% |
| SI-BONE, Inc. | 156.35 Million USD | -434.944% |
| TELA Bio, Inc. | 84.18 Million USD | -893.492% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -1093.889% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -311.276% |
| LivaNova PLC | 843.54 Million USD | 0.848% |
| 908 Devices Inc. | 68.08 Million USD | -1128.541% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -72.952% |
| Nemaura Medical Inc. | 7.13 Million USD | -11616.124% |
| NeuroPace, Inc. | 75.29 Million USD | -1010.804% |
| LENSAR, Inc. | 33.33 Million USD | -2408.972% |
| Apyx Medical Corporation | 51.01 Million USD | -1539.404% |
| Cutera, Inc. | 197.72 Million USD | -323.009% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -3275.13% |
| BioSig Technologies, Inc. | 28.53 Million USD | -2831.619% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -336.815% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -2219.443% |
| Axonics, Inc. | 270.2 Million USD | -209.543% |
| Outset Medical, Inc. | 198.77 Million USD | -320.783% |
| IRIDEX Corporation | 31.81 Million USD | -2529.003% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -364.097% |
| IRadimed Corporation | 30.12 Million USD | -2676.603% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -9702.989% |
| INVO Bioscience, Inc. | 7.85 Million USD | -10550.195% |
| Telesis Bio, Inc. | 63.48 Million USD | -1217.379% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -749.533% |
| Varex Imaging Corporation | 224.8 Million USD | -272.06% |
| Quipt Home Medical Corp. | 148.66 Million USD | -462.594% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7034.616% |
| Pulmonx Corporation | 112.68 Million USD | -642.225% |
| Dynatronics Corporation | 9.9 Million USD | -8341.55% |
| Modular Medical, Inc. | 17.52 Million USD | -4671.47% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -4043.216% |
| Semler Scientific, Inc. | 38.94 Million USD | -2047.676% |
| InMode Ltd. | 215.68 Million USD | -287.793% |
| Bruker Corporation | 1.07 Billion USD | 22.297% |
| Cytosorbents Corporation | 48.33 Million USD | -1630.338% |
| DexCom, Inc. | 1.69 Billion USD | 50.545% |
| Align Technology, Inc. | 2.07 Billion USD | 59.727% |
| Viveve Medical, Inc. | 22.17 Million USD | -3672.115% |
| ZimVie Inc. | 275.12 Million USD | -204.003% |
| Movano Inc. | 29.69 Million USD | -2717.08% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -509.299% |
| Nexalin Technology, Inc. | 5.78 Million USD | -14367.039% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -23607.255% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -39.185% |
| Profound Medical Corp. | 33.6 Million USD | -2389.026% |
| Insulet Corporation | 939.9 Million USD | 11.013% |
| enVVeno Medical Corporation | 25.23 Million USD | -3214.015% |
| Surmodics, Inc. | 98.69 Million USD | -747.433% |
| iCAD, Inc. | 22.22 Million USD | -3663.289% |
| Nuwellis, Inc. | 22.61 Million USD | -3598.718% |
| Biotricity, Inc. | 17.18 Million USD | -4767.11% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -87.578% |
| Aethlon Medical, Inc. | 12.27 Million USD | -6712.382% |
| InspireMD, Inc. | 22.95 Million USD | -3544.405% |
| PAVmed Inc. | 64.82 Million USD | -1190.189% |
| BIOLASE, Inc. | 34.66 Million USD | -2313.061% |
| Beyond Air, Inc. | 61.7 Million USD | -1255.577% |
| FONAR Corporation | 28.6 Million USD | -2823.965% |
| AxoGen, Inc. | 149.33 Million USD | -460.073% |
| Vivani Medical, Inc. | 26.96 Million USD | -3001.765% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -372.292% |
| Inari Medical, Inc. | 448.59 Million USD | -86.446% |
| UFP Technologies, Inc. | 58.08 Million USD | -1339.844% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -16873.601% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -13137.619% |
| Tenon Medical, Inc. | 16.96 Million USD | -4829.226% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -11213.283% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -1796.456% |
| AdaptHealth Corp. | 1.07 Billion USD | 22.41% |
| Sintx Technologies, Inc. | 15.2 Million USD | -5402.21% |
| NanoVibronix, Inc. | 4.97 Million USD | -16718.641% |
| Quanterix Corporation | 118.1 Million USD | -608.206% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -7034.616% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -5691.379% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -113.003% |
| TransMedics Group, Inc. | 182.82 Million USD | -357.494% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -2880.192% |
| NeuroMetrix, Inc. | 11.09 Million USD | -7435.778% |
| Hyperfine, Inc. | 52.87 Million USD | -1481.917% |
| Establishment Labs Holdings Inc. | 172 Million USD | -386.265% |
| Biomerica, Inc. | 6.97 Million USD | -11886.113% |
| Bone Biologics Corporation | 9.42 Million USD | -8771.066% |
| AVITA Medical, Inc. | 80.77 Million USD | -935.404% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -8011.468% |
| Silk Road Medical, Inc | 186.35 Million USD | -348.811% |